A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
Status:
Completed
Trial end date:
2017-10-11
Target enrollment:
Participant gender:
Summary
This is a randomized, double blind, placebo controlled, single ascending dose study to assess
the safety, tolerability, PK, PD and IE with metformin following a single oral dose of
DA-1241 in healthy male subjects.